Douglas Losordo
2022 - Cadrenal Therapeutics
In 2022, Douglas Losordo earned a total compensation of $648.6K as Chief Medical Officer at Cadrenal Therapeutics.
Compensation breakdown
| Option Awards | $625,200 |
|---|---|
| Other | $23,360 |
| Total | $648,560 |
Losordo received $625.2K in option awards, accounting for 96% of the total pay in 2022.
Losordo also received $23.4K in other compensation.
Rankings
In 2022, Douglas Losordo's compensation ranked 3,932nd out of 5,760 executives tracked by ExecPay. In other words, Losordo earned more than 31.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,932 out of 5,760 | 32nd |
Division Manufacturing | 2,224 out of 3,136 | 29th |
Major group Chemicals And Allied Products | 1,078 out of 1,422 | 24th |
Industry group Drugs | 1,012 out of 1,323 | 24th |
Industry Pharmaceutical Preparations | 742 out of 969 | 23rd |
Source: SEC filing on June 11, 2024.
Losordo's colleagues
We found two more compensation records of executives who worked with Douglas Losordo at Cadrenal Therapeutics in 2022.